Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi strikes Crohn’s deal with Glenmark

May 16, 2011
Research and Development Crohn’s disease, Glenmark, Sanofi

Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …

News

Shield Therapeutics appoints finance chief

May 16, 2011
Sales and Marketing appointment, sales and marketing

Swiss specialty pharma company Shield Therapeutics has appointed Richard Jones to the newly-created role of chief financial officer. He has …

Appointment
Merck & Co's Victrelis (boceprevir)

Merck’s hepatitis drug Victrelis approved by FDA

May 16, 2011
Sales and Marketing Merck & Co, Victrelis, boceprevir, hepatitis C

The FDA has approved Merck’s hepatitis C drug Victrelis, the first oral treatment for the disease. Victrelis (boceprevir) has been …

News
ABPI's London offices

ABPI and BIA move in together

May 16, 2011
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA

The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …

News

It’s time we redesigned the clinical trial

May 16, 2011
Research and Development clinical trials, randomised controlled trials

Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …

Feature

Price concession helps change NICE’s mind on Simponi

May 13, 2011
Sales and Marketing NICE, Simponi, TNF, merck sharp and dohme

NICE has provisionally recommended Merck Sharp & Dohme’s Simponi for rheumatoid arthritis alongside other drugs in the TNF inhibitor class. …

News

Takeda denies $12bn Nycomed takeover reports

May 13, 2011
Research and Development, Sales and Marketing Nycomed, Takeda

Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …

News
European Parliament

EMA under fire from European Parliament

May 13, 2011
Medical Communications, Research and Development, Sales and Marketing EMA, European Parliament, MEPs

The EMA has been hit by a barrage of criticism from the European Parliament over conflicts of interest and the …

News

Publicis acquires Beijing-based healthcare agency

May 13, 2011
Medical Communications Publicis Life Brands Dreams, Publicis Life Brands Watermelon, medical communications agency, publicis

Publicis has acquired Dreams Communication, a Chinese agency specialising in healthcare communications. Dreams will become part of Publicis Healthcare Communications …

News

NHS Alliance defends GP commissioning

May 13, 2011
GP commissioning, NHS Alliance, NHS reforms

The NHS Alliance has issued a staunch defence of the principle of GP commissioning – but warned the government to …

News
GlaxoSmithKline

GSK and AZ collaborate on translational research centre

May 12, 2011
Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …

News

SHL Continues to Expand Taiwan Facilities to Support Auto Injector Production

May 12, 2011
Manufacturing and Production assembly, auto injector, autoinjector, automation, cnc, shl group

May 12, 2011 [Taoyuan, Taiwan]: SHL has just completed an additional expansion of its Nan Kan 6 facility located in …

News
Press release

Life appoints head of digital

May 12, 2011
Medical Communications appointment, medical communications

Faisal Ahmed has joined Berkshire, UK-based comms agency Life as head of digital. Faisal’s digital pedigree includes being part of …

Appointment

PCTs increasingly ‘red list’ drugs to cut costs

May 12, 2011
Sales and Marketing GP prescribing deicisions, GPs, PCTs, prescribing

GPs are being asked not to prescribe NICE-approved drugs in order to cut costs. In the last year more than …

Feature

Government wrong to push for Avastin in eye disease, says charity

May 12, 2011
Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD

The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …

News
Roche

Roche aims for wholly personalised skin cancer drug

May 12, 2011
Sales and Marketing Roche, personalised medicine, skin cancer, vemurafenib

Roche has submitted its key skin cancer drug vemurafenib to European and American regulators for approval. Vemurafenib (formerly RG7204) has …

News

AZ signs targeted colon cancer drug collaboration

May 11, 2011
Research and Development AstraZeneca, colorectal cancer, personalised medicine

AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …

News

Drug regulators protect profits over patients, new study finds

May 11, 2011
Research and Development Bad Science, Vioxx, regulatory affairs

Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …

News
Novo Nordisk headquarters

New product can overtake Lantus, says Novo leader

May 11, 2011
Sales and Marketing Novo Nordisk, degludec, diabetes, insulin

Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …

News

Verdict on AMT’s gene therapy expected soon

May 11, 2011
Research and Development, Sales and Marketing AMT, Amsterdam Molecular Therapeutics, gene therapy, genes

Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026